Canopy Growth (NASDAQ:CGC) Corporation (TSX: WEED) (Nasdaq: CGC), a leading cannabis company, announced its financial results for the first quarter ended June 30, 2024, Friday, showcasing a 67% increase in gross profit year-over-year.
Despite a 13% decline in consolidated net revenue, the company reported a gross margin of 35% and a 47% improvement in operating loss from continuing operations compared to the same period last year.
The company's focus on profitable revenue generation has led to a considerable narrowing of its Adjusted EBITDA loss to $5 million, a 77% improvement over the previous year.
The improvement was driven primarily by cost reduction actions already in place. In Canada, the medical cannabis segment saw a 20% increase in net revenue year-over-year, marking its sixth consecutive quarter of growth.
Canopy Growth also reported a 31% reduction in Cost-of-Goods Sold (COGS) and a 24% reduction in Selling General & Administrative (SG&A) expenses over the prior year. The company's cash and short-term investments balance stood at $195 million as of June 30, 2024.
In addition to its financial achievements, Canopy Growth has extended the maturity of its senior secured term loan to December 18, 2026, with an option to further extend to September 18, 2027. The strategic move is expected to enhance the company's financial flexibility and support its growth initiatives.
The company's international market segment experienced a slight decline in net revenue by 1%, with growth in Poland offset by a decline in Australia. Storz & Bickel, a subsidiary of Canopy Growth, saw a 2% increase in net revenue, driven by strong sales growth in Germany and contributions from the Venty portable vaporizer and the Mighty vaporizer.
Looking forward, Canopy Growth's CEO David Klein emphasized the strengthening of the company's business fundamentals and its readiness for growth in the latter half of fiscal 2025. CFO Judy Hong highlighted the company's strategic initiatives leading to improved gross margins and Adjusted EBITDA, as well as a reduction in SG&A expenses.
InvestingPro Insights
Canopy Growth Corporation's latest financial results highlight significant strides in gross profit and operational efficiency. InvestingPro data places the company's market capitalization at $586.62 million, reflecting the market's current valuation of the business. Despite a challenging revenue environment, with a reported decline of 10.83% in revenue over the last twelve months as of Q4 2024, Canopy Growth has managed a gross profit margin of 26.89%, showcasing its ability to maintain profitability in its core operations.
InvestingPro Tips for Canopy Growth indicate that analysts are skeptical about the company's profitability in the near term, which aligns with the reported Adjusted EBITDA loss. However, it's worth noting the company's stock price has seen a large uptick over the last six months, with a 72.14% total return, signaling investor optimism about its growth prospects. Additionally, the company's strategic cost reduction actions are reflected in the significant improvements in operating loss and Adjusted EBITDA, as mentioned in the financial results.
For investors considering Canopy Growth's stock, it's essential to be aware of the volatility in stock price movements. While the company has demonstrated a high return over the last year, with a 47.89% total return, it is quickly burning through cash, which could be a point of concern. There are additional InvestingPro Tips available that could provide further insights into Canopy Growth's financial health and stock performance, which can be found at https://www.investing.com/pro/CGC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.